Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
3,515.00
-200.00 (-5.38%)
Nov 20, 2026, 3:30 PM KST
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 81.75 billion as of November 20, 2026. It is the 28,089th most valuable company in the world and the 1,317th biggest in South Korea. Its market cap has decreased by 63.12% in one year.
Market Cap
81.75B
Enterprise Value
43.71B
Revenue
n/a
Global Rank
Country Rank
#1,317 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has decreased from 160.24B to 81.75B, a decrease of -48.98%. That is a compound annual growth rate of -10.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 81.75B | -64.81% |
| Dec 30, 2025 | 232.34B | -3.12% |
| Dec 30, 2024 | 239.82B | -53.54% |
| Dec 28, 2023 | 516.20B | -0.71% |
| Dec 29, 2022 | 519.87B | -21.31% |
| Dec 30, 2021 | 660.68B | -73.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GC Cell | 148.32B |
| Helixmith | 146.20B |
| NeoImmuneTech | 139.40B |
| Anterogen.Co.,Ltd. | 129.88B |
| MedPacto | 125.28B |
| HLB Therapeutics | 102.77B |
| Genexine | 80.77B |
| iNtRON Biotechnology | 76.77B |